Harvard Bioscience (HBIO) Debt Ratio (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Debt Ratio data on file, last reported at 0.46 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.46, up 3.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46 (up 3.11% YoY), and the FY2025 annual result was 0.45, up 53.52% from the prior year.
• Debt Ratio advanced to 0.46 in Q1 2026 per HBIO's latest filing, from 0.45 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.46 in Q1 2026 and troughed at 0.27 in Q4 2023.
• A 5-year average of 0.34 and a median of 0.31 in 2022 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2023 and 2025: Debt Ratio fell 17.37% in 2023, then soared 68.5% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.32 in 2022, then slipped by 17.37% to 0.27 in 2023, then climbed by 9.63% to 0.29 in 2024, then surged by 53.52% to 0.45 in 2025, then climbed by 3.71% to 0.46 in 2026.
• Business Quant data shows HBIO's Debt Ratio at 0.46 in Q1 2026, 0.45 in Q4 2025, and 0.44 in Q3 2025.